Veterinary Medicines

Cloxin TS-Retard-Injektor

Authorised
  • Cloxacillin sodium monohydrate
  • Cloxacillin hemibenzathine
Download as PDF

Product identification

Medicine name:
Cloxin TS-Retard-Injektor
Active substance:
  • Cloxacillin sodium monohydrate
  • Cloxacillin hemibenzathine
Target species:
  • Cattle (dairy cow)
Route of administration:
  • Intramammary use

Product details

Active substance and strength:
  • Cloxacillin sodium monohydrate
    200.00
    milligram(s)
    /
    8.00
    gram(s)
  • Cloxacillin hemibenzathine
    800.00
    milligram(s)
    /
    8.00
    gram(s)
Pharmaceutical form:
  • Intramammary suspension
Withdrawal period by route of administration:
  • Intramammary use
    • Cattle (dairy cow)
      • Meat and offal
        5
        day
      • Milk
        5
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ51CF02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Germany
Available in:
  • Germany
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • Veyx Pharma GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Veyx Pharma GmbH
Responsible authority:
  • Federal Office Of Consumer Protection And Food Safety
Authorisation number:
  • 4658.00.00
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 24/01/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."